Navigation Links
Angioplasty The Much Preferred Treatment Of Choice For Heart Attacks

A new study finds angioplasty should be the treatment of choice for heart attack patients, even if the hospital they initially go to doesn’t offer angioplasty// services and they have to be transferred to another facility for treatment.

Research has shown heart attack patients fare better when they are treated with angioplasty to open up the clogged blood vessel that caused the attack than when they are treated with a clot-busting drug therapy called fibrinolysis.

Danish researchers involved around 1,500 heart attack patients in their study from 24 hospitals without angioplasty services and five hospitals with such services. Patients at the 24 hospitals were randomly assigned to either treatment with fibrinolysis at the facility where they were first admitted or treatment with angioplasty at another hospital that offered the service, if they could be transferred to the new hospital within two hours.

Researchers analyzed results, looking at a combination of death, clinical evidence of another heart attack (reinfarction), or a disabling stroke within 30 days. Results showed patients who received angioplasty were significantly more likely to survive, regardless of whether they had been transferred to another hospital to receive the angioplasty or not. Overall, only 8.5 percent of the angioplasty group suffered a complication, compared to 14.2 percent of those in the fibrinolysis group. The primary benefit was a reduction in the rate of reinfarction among the angioplasty patients. Little difference was noted between the groups in death or stroke rates.
'"/>




Page: 1

Related medicine news :

1. Cholesterol Drug Helps After Angioplasty
2. Angioplasty Should be the Standard
3. The Success Rate Of Angioplasty In Female Patients Low
4. Angioplasty death risk reduced by doubling drug dose
5. Angioplasty death risk reduced by doubling drug dose
6. A ray of hope in Angioplasty dilemma
7. Angioplasty plus stenting better than thrombolysis for elderly patients with AMI
8. Patients Fare Better With Doctors Who Do More Angioplasty Procedures
9. Researchers Begin Study To Find Out If Angioplasty Can Be Safely Done In Smaller Hospitals
10. Drug-Coated Stents Work Better In Diabetic Patients After Angioplasty
11. Togadiyas Condition Stable After Undergoing Angioplasty
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/7/2016)... ... December 07, 2016 , ... A quote from Dr. Edward Hallowell, host of ... media that offer a rare glimpse into the mind of those people with ADHD. ... Times bestselling author, has described people with ADHD as having “Ferrari engines for a ...
(Date:12/7/2016)... MI (PRWEB) , ... December 07, 2016 , ... ... and financial consultation services from offices located in South Lyon, Dewitt, Williamston, East ... benefit a basketball coach who needs treatment for a brain tumor. , Jason ...
(Date:12/7/2016)... ... , ... A. Kevin Spann Insurance, a New York-based firm offering insurance and ... a charity drive to raise funds that will benefit the Marine Corps League. , ... Navy FMF Corpsmen. Working closely with the MCL, the A. Kevin Spann team plans ...
(Date:12/7/2016)... Phoenix, Arizona (PRWEB) , ... December 07, 2016 , ... ... Juvederm®, Just in Time For The Holiday Party Season. Save Up To 33% Off ... and Laser Salon is providing the Phoenix Valley with Delightful Deals on ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... Business Brilliance Awards under the Best New Product Launch category. Gensuite’s entry on ... user experience. , BOC Global Events & Training Group is a professional event ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... Inc. (NASDAQ: IONS ), the leader in antisense therapeutics, ... BMO Capital Markets Prescriptions for Success Healthcare Conference on Wednesday, December ... A live webcast of the presentation will be available on the ... be available within 48 hours and will be archived for a ... , , ...
(Date:12/7/2016)... Inc. (NYSE: LCI ) today announced that the company ... Healthcare Conference on December 14, 2016 at 9:20 a.m. (ET) at ... . In addition, the company will host one-on-one meetings ... Annual Boston Healthcare Conference taking place on December 13, 2016 at ... , ...
(Date:12/6/2016)... 2016  Alopexx Oncology, LLC announced data from a ... protein (immunocytokine) composed of interleukin-2 and a CD20-targeting monoclonal ... B cells as Rituxan and maintains the activities of ... involved in tumor targeting, engagement of the immune system, ... of the study (abstract #95954) were presented at the ...
Breaking Medicine Technology: